Literature DB >> 28891459

Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.

N H Zainul1, Z F Ma1, A Besari1, H Siti Asma2, R A Rahman2, D A Collins3, N Hamid1, T V Riley3, Y Y Lee1.   

Abstract

Little is known about Clostridium difficile infection (CDI) in Asia. The aims of our study were to explore (i) the prevalence, risk factors and molecular epidemiology of CDI and colonization in a tertiary academic hospital in North-Eastern Peninsular Malaysia; (ii) the rate of carriage of C. difficile among the elderly in the region; (iii) the awareness level of this infection among the hospital staffs and students. For stool samples collected from hospital inpatients with diarrhea (n = 76) and healthy community members (n = 138), C. difficile antigen and toxins were tested by enzyme immunoassay. Stool samples were subsequently analyzed by culture and molecular detection of toxin genes, and PCR ribotyping of isolates. To examine awareness among hospital staff and students, participants were asked to complete a self-administered questionnaire. For the hospital and community studies, the prevalence of non-toxigenic C. difficile colonization was 16% and 2%, respectively. The prevalence of CDI among hospital inpatients with diarrhea was 13%. Out of 22 C. difficile strains from hospital inpatients, the toxigenic ribotypes 043 and 017 were most common (both 14%). In univariate analysis, C. difficile colonization in hospital inpatients was significantly associated with greater duration of hospitalization and use of penicillin (both P < 0·05). Absence of these factors was a possible reason for low colonization in the community. Only 3% of 154 respondents answered all questions correctly in the awareness survey. C. difficile colonization is prevalent in a Malaysian hospital setting but not in the elderly community with little or no contact with hospitals. Awareness of CDI is alarmingly poor.

Entities:  

Keywords:  zzm321990 Clostridium difficilezzm321990 ; Awareness; elderly; epidemiology; patients; prevalence; risk factors

Mesh:

Year:  2017        PMID: 28891459      PMCID: PMC9152746          DOI: 10.1017/S0950268817002011

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  36 in total

1.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

2.  Clostridium difficile associated diarrhoea: a report of seven cases.

Authors:  N Parasakthi; S D Puthucheary; K L Goh; V Sivanesaratnam
Journal:  Singapore Med J       Date:  1988-10       Impact factor: 1.858

3.  Underestimation of Clostridium difficile infection among clinicians: an international survey.

Authors:  M N Mavros; V G Alexiou; K Z Vardakas; K Tsokali; T A Sardi; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-27       Impact factor: 3.267

Review 4.  Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.

Authors:  Gayatri Vedantam; Andrew Clark; Michele Chu; Rebecca McQuade; Michael Mallozzi; V K Viswanathan
Journal:  Gut Microbes       Date:  2012-03-01

5.  Recommendations for surveillance of Clostridium difficile-associated disease.

Authors:  L Clifford McDonald; Bruno Coignard; Erik Dubberke; Xiaoyan Song; Teresa Horan; Preeta K Kutty
Journal:  Infect Control Hosp Epidemiol       Date:  2007-01-25       Impact factor: 3.254

Review 6.  Clostridium difficile infection.

Authors:  Latisha Heinlen; Jimmy D Ballard
Journal:  Am J Med Sci       Date:  2010-09       Impact factor: 2.378

7.  Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea.

Authors:  Stuart McPherson; Colin J Rees; Richard Ellis; Shelly Soo; Simon J Panter
Journal:  Dis Colon Rectum       Date:  2006-05       Impact factor: 4.585

8.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  Prevalence and molecular epidemiology of Clostridium difficile infection in Thailand.

Authors:  P Putsathit; M Maneerattanaporn; P Piewngam; P Kiratisin; T V Riley
Journal:  New Microbes New Infect       Date:  2016-10-21

Review 10.  The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation.

Authors:  Amy Langdon; Nathan Crook; Gautam Dantas
Journal:  Genome Med       Date:  2016-04-13       Impact factor: 11.117

View more
  5 in total

1.  High Prevalence of Toxigenic and Nontoxigenic Clostridium difficile Strains in Malaysia.

Authors:  Thomas V Riley; Deirdre A Collins; Rina Karunakaran; Maria Abdul Kahar; Ariza Adnan; Siti Asma Hassan; Nadiah Hanim Zainul; F R Mohammed Rustam; Z Abd Wahab; Ramliza Ramli; Yeong Yeh Lee; Hamimah Hassan
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

2.  Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.

Authors:  Peng An Khun; Thomas V Riley
Journal:  Am J Trop Med Hyg       Date:  2022-08-08       Impact factor: 3.707

Review 3.  2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.

Authors:  Massimo Sartelli; Stefano Di Bella; Lynne V McFarland; Sahil Khanna; Luis Furuya-Kanamori; Nadir Abuzeid; Fikri M Abu-Zidan; Luca Ansaloni; Goran Augustin; Miklosh Bala; Offir Ben-Ishay; Walter L Biffl; Stephen M Brecher; Adrián Camacho-Ortiz; Miguel A Caínzos; Shirley Chan; Jill R Cherry-Bukowiec; Jesse Clanton; Federico Coccolini; Maria E Cocuz; Raul Coimbra; Francesco Cortese; Yunfeng Cui; Jacek Czepiel; Zaza Demetrashvili; Isidoro Di Carlo; Salomone Di Saverio; Irina M Dumitru; Christian Eckmann; Edward H Eiland; Joseph D Forrester; Gustavo P Fraga; Jean L Frossard; Donald E Fry; Rita Galeiras; Wagih Ghnnam; Carlos A Gomes; Ewen A Griffiths; Xavier Guirao; Mohamed H Ahmed; Torsten Herzog; Jae Il Kim; Tariq Iqbal; Arda Isik; Kamal M F Itani; Francesco M Labricciosa; Yeong Y Lee; Paul Juang; Aleksandar Karamarkovic; Peter K Kim; Yoram Kluger; Ari Leppaniemi; Varut Lohsiriwat; Gustavo M Machain; Sanjay Marwah; John E Mazuski; Gokhan Metan; Ernest E Moore; Frederick A Moore; Carlos A Ordoñez; Leonardo Pagani; Nicola Petrosillo; Francisco Portela; Kemal Rasa; Miran Rems; Boris E Sakakushev; Helmut Segovia-Lohse; Gabriele Sganga; Vishal G Shelat; Patrizia Spigaglia; Pierre Tattevin; Cristian Tranà; Libor Urbánek; Jan Ulrych; Pierluigi Viale; Gian L Baiocchi; Fausto Catena
Journal:  World J Emerg Surg       Date:  2019-02-28       Impact factor: 5.469

4.  Clostridioides difficile infection in the Asia-Pacific region.

Authors:  Deirdre A Collins; Kyung Mok Sohn; Yuan Wu; Kentaro Ouchi; Yoshikazu Ishii; Briony Elliott; Thomas V Riley; Kazuhiro Tateda
Journal:  Emerg Microbes Infect       Date:  2019-12-24       Impact factor: 7.163

5.  Loop mediated isothermal amplification of Clostridioides difficile isolates in gastrointestinal patients.

Authors:  Mojtaba Moosavian; Razieyeh Keshavarzi; Effat Abbasi Montazeri; Eskandar Hajiani
Journal:  AMB Express       Date:  2022-04-12       Impact factor: 3.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.